Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.
Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity (IMMUNITY, CELLULAR) and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria.
Radiotherapy given to augment some other form of treatment such as surgery or chemotherapy. Adjuvant radiotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment.
Agents that aid or increase the action of the principle drug (DRUG SYNERGISM) or that affect the absorption, mechanism of action, metabolism, or excretion of the primary drug (PHARMACOKINETICS) in such a way as to enhance its effects.
Tumors or cancer of the human BREAST.
A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow).
One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM.
A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079)
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases.
Delivery of medications through the nasal mucosa.
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS.
Vaccines consisting of one or more antigens that stimulate a strong immune response. They are purified from microorganisms or produced by recombinant DNA techniques, or they can be chemically synthesized peptides.
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis.
An albumin obtained from the white of eggs. It is a member of the serpin superfamily.
Nonsusceptibility to the pathogenic effects of foreign microorganisms or antigenic substances as a result of antibody secretions of the mucous membranes. Mucosal epithelia in the gastrointestinal, respiratory, and reproductive tracts produce a form of IgA (IMMUNOGLOBULIN A, SECRETORY) that serves to protect these ports of entry into the body.
An antihelminthic drug that has been tried experimentally in rheumatic disorders where it apparently restores the immune response by increasing macrophage chemotaxis and T-lymphocyte function. Paradoxically, this immune enhancement appears to be beneficial in rheumatoid arthritis where dermatitis, leukopenia, and thrombocytopenia, and nausea and vomiting have been reported as side effects. (From Smith and Reynard, Textbook of Pharmacology, 1991, p435-6)
Substances that inhibit or prevent the proliferation of NEOPLASMS.
A type of glycoside widely distributed in plants. Each consists of a sapogenin as the aglycone moiety, and a sugar. The sapogenin may be a steroid or a triterpene and the sugar may be glucose, galactose, a pentose, or a methylpentose.
Compounds that inhibit AROMATASE in order to reduce production of estrogenic steroid hormones.
Sorbitan mono-9-octadecanoate poly(oxy-1,2-ethanediyl) derivatives; complex mixtures of polyoxyethylene ethers used as emulsifiers or dispersing agents in pharmaceuticals.
An ENTEROTOXIN from VIBRIO CHOLERAE. It consists of two major protomers, the heavy (H) or A subunit and the B protomer which consists of 5 light (L) or B subunits. The catalytic A subunit is proteolytically cleaved into fragments A1 and A2. The A1 fragment is a MONO(ADP-RIBOSE) TRANSFERASE. The B protomer binds cholera toxin to intestinal epithelial cells, and facilitates the uptake of the A1 fragment. The A1 catalyzed transfer of ADP-RIBOSE to the alpha subunits of heterotrimeric G PROTEINS activates the production of CYCLIC AMP. Increased levels of cyclic AMP are thought to modulate release of fluid and electrolytes from intestinal crypt cells.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
Peptidoglycan immunoadjuvant originally isolated from bacterial cell wall fragments; also acts as pyrogen and may cause arthritis; stimulates both humoral and cellular immunity.
Vaccines or candidate vaccines designed to prevent or treat cancer. Vaccines are produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced.
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA.
They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
Elements of limited time intervals, contributing to particular results or situations.
An increased reactivity to specific antigens mediated not by antibodies but by cells.
Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.
An anthracycline which is the 4'-epi-isomer of doxorubicin. The compound exerts its antitumor effects by interference with the synthesis and function of DNA.
Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important.
A formulation for presenting an antigen to induce specific immunologic responses. It consists of an assembly of antigens in multimeric form. The assembly is attached to a matrix with a built-in adjuvant, saponin. ISCOMs induce strong serum antibody responses, and are used as highly immunogenic forms of subunit vaccines.
Recombinant DNA vectors encoding antigens administered for the prevention or treatment of disease. The host cells take up the DNA, express the antigen, and present it to the immune system in a manner similar to that which would occur during natural infection. This induces humoral and cellular immune responses against the encoded antigens. The vector is called naked DNA because there is no need for complex formulations or delivery agents; the plasmid is injected in saline or other buffers.
Surgical procedure to remove one or both breasts.
Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.
Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN.
Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.
Lipid A is the biologically active component of lipopolysaccharides. It shows strong endotoxic activity and exhibits immunogenic properties.
A malignant epithelial tumor with a glandular organization.
Tumors or cancer of the COLON.
Antibody-mediated immune response. Humoral immunity is brought about by ANTIBODY FORMATION, resulting from TH2 CELLS activating B-LYMPHOCYTES, followed by COMPLEMENT ACTIVATION.
Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role.
Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries.
The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS.
Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE.
Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage.
Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.
Substances that are recognized by the immune system and induce an immune reaction.
Subset of helper-inducer T-lymphocytes which synthesize and secrete interleukin-2, gamma-interferon, and interleukin-12. Due to their ability to kill antigen-presenting cells and their lymphokine-mediated effector activity, Th1 cells are associated with vigorous delayed-type hypersensitivity reactions.
Vaccines in which the infectious microbial nucleic acid components have been destroyed by chemical or physical treatment (e.g., formalin, beta-propiolactone, gamma radiation) without affecting the antigenicity or immunogenicity of the viral coat or bacterial outer membrane proteins.
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
Organic compounds that have a tetrahydronaphthacenedione ring structure attached by a glycosidic linkage to the amino sugar daunosamine.
Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION).
Vaccines used to prevent infection by viruses in the family ORTHOMYXOVIRIDAE. It includes both killed and attenuated vaccines. The composition of the vaccines is changed each year in response to antigenic shifts and changes in prevalence of influenza virus strains. The vaccine is usually bivalent or trivalent, containing one or two INFLUENZAVIRUS A strains and one INFLUENZAVIRUS B strain.
Antimetabolites that are useful in cancer chemotherapy.
A cell surface protein-tyrosine kinase receptor that is overexpressed in a variety of ADENOCARCINOMAS. It has extensive homology to and heterodimerizes with the EGF RECEPTOR, the ERBB-3 RECEPTOR, and the ERBB-4 RECEPTOR. Activation of the erbB-2 receptor occurs through heterodimer formation with a ligand-bound erbB receptor family member.
An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle.
The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES.
Tumors or cancer of the RECTUM.
A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell.
A plant genus of the family ROSACEAE whose members produce SAPONINS.
An encapsulated lymphatic organ through which venous blood filters.
Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin.
Immunoglobulins produced in a response to BACTERIAL ANTIGENS.
Any immunization following a primary immunization and involving exposure to the same or a closely related antigen.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
Non-antibody proteins secreted by inflammatory leukocytes and some non-leukocytic cells, that act as intercellular mediators. They differ from classical hormones in that they are produced by a number of tissue or cell types rather than by specialized glands. They generally act locally in a paracrine or autocrine rather than endocrine manner.
Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION.
Immunoglobulins produced in response to VIRAL ANTIGENS.
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection.
Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
The giving of drugs, chemicals, or other substances by mouth.
Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966)
Congener of FLUOROURACIL with comparable antineoplastic action. It has been suggested especially for the treatment of breast neoplasms.
A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445)
Vaccines made from antigens arising from any of the four strains of Plasmodium which cause malaria in humans, or from P. berghei which causes malaria in rodents.
Toxic glycolipids composed of trehalose dimycolate derivatives. They are produced by MYCOBACTERIUM TUBERCULOSIS and other species of MYCOBACTERIUM. They induce cellular dysfunction in animals.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.
Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives.
Removal of only enough breast tissue to ensure that the margins of the resected surgical specimen are free of tumor.
A mixture of liquid hydrocarbons obtained from petroleum. It is used as laxative, lubricant, ointment base, and emollient.
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.
Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions.
Colloids formed by the combination of two immiscible liquids such as oil and water. Lipid-in-water emulsions are usually liquid, like milk or lotion. Water-in-lipid emulsions tend to be creams. The formation of emulsions may be aided by amphiphatic molecules that surround one component of the system to form MICELLES.
The physiological period following the MENOPAUSE, the permanent cessation of the menstrual life.
The period before MENOPAUSE. In premenopausal women, the climacteric transition from full sexual maturity to cessation of ovarian cycle takes place between the age of late thirty and early fifty.
The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer.
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.
An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed.
Substances elaborated by bacteria that have antigenic activity.
A group of deoxyribonucleotides (up to 12) in which the phosphate residues of each deoxyribonucleotide act as bridges in forming diester linkages between the deoxyribose moieties.
A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Certain tumors that 1, arise in organs that are normally dependent on specific hormones and 2, are stimulated or caused to regress by manipulation of the endocrine environment.
Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria.
Subset of helper-inducer T-lymphocytes which synthesize and secrete the interleukins IL-4, IL-5, IL-6, and IL-10. These cytokines influence B-cell development and antibody production as well as augmenting humoral responses.
Tumors or cancer of the LUNG.
A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
A critical subpopulation of regulatory T-lymphocytes involved in MHC Class I-restricted interactions. They include both cytotoxic T-lymphocytes (T-LYMPHOCYTES, CYTOTOXIC) and CD8+ suppressor T-lymphocytes.
4-Methyl derivative of LOMUSTINE; (CCNU). An antineoplastic agent which functions as an alkylating agent.
An active immunizing agent and a viable avirulent attenuated strain of Mycobacterium tuberculosis, var. bovis, which confers immunity to mycobacterial infections. It is used also in immunotherapy of neoplasms due to its stimulation of antibodies and non-specific immunity.
The principle immunoglobulin in exocrine secretions such as milk, respiratory and intestinal mucin, saliva and tears. The complete molecule (around 400 kD) is composed of two four-chain units of IMMUNOGLOBULIN A, one SECRETORY COMPONENT and one J chain (IMMUNOGLOBULIN J-CHAINS).
Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases.
A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.
A group of diterpenoid CYCLODECANES named for the taxanes that were discovered in the TAXUS tree. The action on MICROTUBULES has made some of them useful as ANTINEOPLASTIC AGENTS.
Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
Antibodies from non-human species whose protein sequences have been modified to make them nearly identical with human antibodies. If the constant region and part of the variable region are replaced, they are called humanized. If only the constant region is modified they are called chimeric. INN names for humanized antibodies end in -zumab.
The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells.
Proteins prepared by recombinant DNA technology.
Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
Histochemical localization of immunoreactive substances using labeled antibodies as reagents.
Tumors or cancer of the STOMACH.
Vaccines or candidate vaccines used to prevent or treat TUBERCULOSIS.
Substances that possess antiestrogenic actions but can also produce estrogenic effects as well. They act as complete or partial agonist or as antagonist. They can be either steroidal or nonsteroidal in structure.
Antibodies produced by a single clone of cells.
Works about comparative studies to verify the effectiveness of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques determined in phase II studies. During these trials, patients are monitored closely by physicians to identify any adverse reactions from long-term use. These studies are performed on groups of patients large enough to identify clinically significant responses and usually last about three years. This concept includes phase III studies conducted in both the U.S. and in other countries.
A cyclodecane isolated from the bark of the Pacific yew tree, TAXUS BREVIFOLIA. It stabilizes MICROTUBULES in their polymerized form leading to cell death.
The return of a sign, symptom, or disease after a remission.
The use of IONIZING RADIATION to treat malignant NEOPLASMS and some benign conditions.
Vaccines or candidate vaccines containing inactivated HIV or some of its component antigens and designed to prevent or treat AIDS. Some vaccines containing antigens are recombinantly produced.
Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.
A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026)
Forceful administration into the peritoneal cavity of liquid medication, nutrient, or other fluid through a hollow needle piercing the abdominal wall.
A heterodimeric cytokine that plays a role in innate and adaptive immune responses. Interleukin-12 is a 70 kDa protein that is composed of covalently linked 40 kDa and 35 kDa subunits. It is produced by DENDRITIC CELLS; MACROPHAGES and a variety of other immune cells and plays a role in the stimulation of INTERFERON-GAMMA production by T-LYMPHOCYTES and NATURAL KILLER CELLS.
Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2.
Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins.
Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system.
Immunoglobulins produced in a response to PROTOZOAN ANTIGENS.
Ability of neoplasms to infiltrate and actively destroy surrounding tissue.
Excision of the whole (total gastrectomy) or part (subtotal gastrectomy, partial gastrectomy, gastric resection) of the stomach. (Dorland, 28th ed)
The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
Removal of the breast, pectoral muscles, axillary lymph nodes, and associated skin and subcutaneous tissue.
A double-stranded polyribonucleotide comprising polyadenylic and polyuridylic acids.
A subspecialty of internal medicine concerned with the study of neoplasms.
Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered.
Organic compounds which contain platinum as an integral part of the molecule.
An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564)
Absence of menstruation.
The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed)
The application of probability and statistical methods to calculate the risk of occurrence of any event, such as onset of illness, recurrent disease, hospitalization, disability, or death. It may include calculation of the anticipated money costs of such events and of the premiums necessary to provide for payment of such costs.
A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)
A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer.
Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
The relationship between the dose of an administered drug and the response of the organism to the drug.
A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)
Area of the human body underneath the SHOULDER JOINT, also known as the armpit or underarm.
Total mastectomy with axillary node dissection, but with preservation of the pectoral muscles.
Tumors or cancer of the SKIN.
Tumors or cancer located in bone tissue or specific BONES.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research.
Used for excision of the urinary bladder.
The classes of immunoglobulins found in any species of animal. In man there are nine classes that migrate in five different groups in electrophoresis; they each consist of two light and two heavy protein chains, and each group has distinguishing structural and functional properties.
Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances.
Inflammation of a TESTIS. It has many features of EPIDIDYMITIS, such as swollen SCROTUM; PAIN; PYURIA; and FEVER. It is usually related to infections in the URINARY TRACT, which likely spread to the EPIDIDYMIS and then the TESTIS through either the VAS DEFERENS or the lymphatics of the SPERMATIC CORD.
The total amount of radiation absorbed by tissues as a result of radiotherapy.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63)
Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides.
Resistance to a disease agent resulting from the production of specific antibodies by the host, either after exposure to the disease or after vaccination.
An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
Clinical protocols used to inhibit the growth or spread of NEOPLASMS.
A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.
An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).
Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER).
Abnormal growths of tissue that follow a previous neoplasm but are not metastases of the latter. The second neoplasm may have the same or different histological type and can occur in the same or different organs as the previous neoplasm but in all cases arises from an independent oncogenic event. The development of the second neoplasm may or may not be related to the treatment for the previous neoplasm since genetic risk or predisposing factors may actually be the cause.

Acarbose is an effective adjunct to dietary therapy in the treatment of hypertriglyceridaemias. (1/102)

AIMS: In diabetics, acarbose causes a reduction of blood glucose and triglyceride levels. The aim of this study was to assess the effect of this drug in non diabetic subjects with hypertriglyceridaemia. METHODS: Thirty non diabetic patients with hypertriglyceridaemia type IIb or IV (24 males, six females; mean age 51.1+/-10.2 years) were studied. They were stratified into two groups depending on their basal triglyceride concentration (group A: triglyceride values 4.5 mmol l-1 ). Treatment consisted of 4 week courses of diet plus acarbose (50 mg twice daily) alternating with 4 weeks of diet alone for a total period of 16 weeks. RESULTS: Mean triglyceride values decreased significantly during the first and third cycles of therapy, i.e. diet plus acarbose treatment cycles in both patient groups. Group A also had significant reductions in total cholesterol and HDL cholesterol concentrations after completion of the acarbose treatment. Reduction of triglyceride levels was observed after both acarbose courses in patients affected by hypertriglyceridaemia type IIb. A marked reduction of triglyceride concentrations was achieved by patients affected by hypertriglyceridaemia type IV after the second acarbose course only. CONCLUSIONS: Diet alone did not reduce triglyceride concentrations to normal values in our patients. The data suggest that acarbose is a useful adjunct to dietary control in non-diabetic patients affected by severe hypertriglyceridaemia.  (+info)

Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor. (2/102)

We successfully treated 3 consecutive patients who had nonneutropenic rhinocerebral zygomycosis, by use of subcutaneous granulocyte-macrophage colony-stimulating factor therapy combined with traditional surgical and medical treatment. All patients are currently free of disease. Granulocyte-macrophage colony-stimulating factor should be considered as adjuvant therapy for rhinocerebral zygomycosis; however, optimum dose and length of therapy are unknown.  (+info)

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. (3/102)

OBJECTIVE: Our goal was to provide health-care providers, patients, and the general public with an assessment of currently available data regarding the use of adjuvant therapy for breast cancer. PARTICIPANTS: The participants included a non-Federal, non-advocate, 14-member panel representing the fields of oncology, radiology, surgery, pathology, statistics, public health, and health policy as well as patient representatives. In addition, 30 experts in medical oncology, radiation oncology, biostatistics, epidemiology, surgical oncology, and clinical trials presented data to the panel and to a conference audience of 1000. EVIDENCE: The literature was searched with the use of MEDLINE(TM) for January 1995 through July 2000, and an extensive bibliography of 2230 references was provided to the panel. Experts prepared abstracts for their conference presentations with relevant citations from the literature. Evidence from randomized clinical trials and evidence from prospective studies were given precedence over clinical anecdotal experience. CONSENSUS PROCESS: The panel, answering predefined questions, developed its conclusions based on the evidence presented in open forum and the scientific literature. The panel composed a draft statement, which was read in its entirety and circulated to the experts and the audience for comment. Thereafter, the panel resolved conflicting recommendations and released a revised statement at the end of the conference. The panel finalized the revisions within a few weeks after the conference. The draft statement was made available on the World Wide Web immediately after its release at the conference and was updated with the panel's final revisions. The statement is available at CONCLUSIONS: The panel concludes that decisions regarding adjuvant hormonal therapy should be based on the presence of hormone receptor protein in tumor tissues. Adjuvant hormonal therapy should be offered only to women whose tumors express hormone receptor protein. Because adjuvant polychemotherapy improves survival, it should be recommended to the majority of women with localized breast cancer regardless of lymph node, menopausal, or hormone receptor status. The inclusion of anthracyclines in adjuvant chemotherapy regimens produces a small but statistically significant improvement in survival over non-anthracycline-containing regimens. Available data are currently inconclusive regarding the use of taxanes in adjuvant treatment of lymph node-positive breast cancer. The use of adjuvant dose-intensive chemotherapy regimens in high-risk breast cancer and of taxanes in lymph node-negative breast cancer should be restricted to randomized trials. Ongoing studies evaluating these treatment strategies should be supported to determine if such strategies have a role in adjuvant treatment. Studies to date have included few patients older than 70 years. There is a critical need for trials to evaluate the role of adjuvant chemotherapy in these women. There is evidence that women with a high risk of locoregional tumor recurrence after mastectomy benefit from postoperative radiotherapy. This high-risk group includes women with four or more positive lymph nodes or an advanced primary cancer. Currently, the role of postmastectomy radiotherapy for patients with one to three positive lymph nodes remains uncertain and should be tested in a randomized controlled trial. Individual patients differ in the importance they place on the risks and benefits of adjuvant treatments. Quality of life needs to be evaluated in selected randomized clinical trials to examine the impact of the major acute and long-term side effects of adjuvant treatments, particularly premature menopause, weight gain, mild memory loss, and fatigue. Methods to support shared decision-making between patients and their physicians have been successful in trials; they need to be tailored for diverse populations and should be tested for broader dissemination.  (+info)

Initial experience of platelet glycoprotein IIb/IIIa inhibition with abciximab during carotid stenting: a safe and effective adjunctive therapy. (4/102)

BACKGROUND AND PURPOSE: Abciximab has been shown to decrease periprocedural ischemic complications after coronary intervention. However, the adjunctive use of abciximab in carotid stenting has not been adequately studied. We sought to determine the efficacy and safety of abciximab in carotid stenting. METHODS: Carotid stenting was performed in 151 consecutive patients determined to be at high surgical risk by a vascular surgeon. Of these, 128 consecutive patients received adjuvant therapy with abciximab (0.25 mg/kg bolus before the lesion was crossed with guidewire and 0.125 micro. kg(-1). min(-1) infusion for 12 hours.). A heparin bolus of 50 U/kg was given, and activated clotting time was maintained between 250 to 300 seconds. All patients received aspirin and thienopyridine. Procedural and 30-day outcomes were compared between the control (n=23) and abciximab (n=128) groups. RESULTS: The 2 groups had similar baseline characteristics. Procedural events were more frequent in the control group (8%; 1 major stroke and 1 neurological death) compared with the abciximab group (1.6%; 1 minor stroke and 1 retinal infarction; P=0.05). On 30-day follow-up, 1 patient presented with delayed intracranial hemorrhage in the abciximab group. There were no other major bleeding complications. CONCLUSIONS: Adjunctive use of abciximab for carotid stenting is safe with no increase in the risk of intracranial hemorrhage. This adjunctive therapy with potent glycoprotein IIb/IIIa inhibition may help to reduce periprocedural adverse events in patients undergoing carotid stenting.  (+info)

Felbamate, gabapentin and topiramate as adjuvant antiepileptic drugs in experimental models of epilepsy. (5/102)

Newly diagnosed epileptic patients start their medication with monotherapy. Around 30% of epileptic patients require more than one antiepileptic drug. Results from experimental studies provide evidence that administration of two antiepileptic drugs may result in antagonistic, additive, or supra-additive (synergistic) anticonvulsant effects. If adverse effects of a synergistic combination also show supra-additive summation then the protective index may not change. In this context, drug combinations, possessing synergistic anticonvulsant effects and additive (or infra-additive) toxicity, are of clinical interest. Recent experimental data indicate that topiramate and gabapentin generally potentiate the protective activity of conventional antiepileptic drugs against maximal electroshock-induced convulsions in mice. The anticonvulsant action of carbamazepine, diphenylhydantoin, phenobarbital, and valproate was not modified in this test by felbamate at subprotective doses against threshold electroconvulsions. Interestingly, conventional antiepileptics (at subeffective doses) enhanced the protection offered by felbamate. It may indicate that beneficial effects of a drug combination may be observed at only some drug ratios.  (+info)

Adjuvant L-arginine treatment in controlled ovarian hyperstimulation: a double-blind, randomized study. (6/102)

BACKGROUND: Enhanced vascularization appears to be important for follicular selection and maturation in both spontaneous and stimulated IVF cycles. Nitric oxide, formed in vivo from L-arginine, may play a key role in follicular maturation and ovulation. METHODS: To evaluate the role of L-arginine supplementation in controlled ovarian hyperstimulation, 37 IVF patients were divided into two groups according to ovarian stimulation protocols: group I, GnRH agonist plus pure (p)FSH plus oral L-arginine (n = 18); and group II, GnRH agonist plus pFSH plus placebo (n = 19). Hormonal, ultrasonographic and Doppler evaluations were performed, and plasma and follicular fluid nitrite/nitrate concentrations were monitored. RESULTS: Thirty-two patients completed the study. In group I (n = 16), plasma L-arginine concentrations increased from (basal) 87 +/- 12 micromol to 279 +/- 31 micromol (P = 0.002) on the day of beta-HCG administration. In this group, pFSH treatment was shorter (P = 0.039) than in group II (n = 16). The number of the follicles > or =17mm was lower (P = 0.038) in group I than group II. The "good quality" embryos were fewer in number (P = 0.034) and pregnancy rate, both per patient (P = 0.024) and per embryo transfer (P = 0.019), was lower in group I. In the L-arginine group, an increased follicular fluid concentration of nitrite/nitrate was observed. On day 8 of the cycle, elevated plasma estradiol levels were associated with decreased blood flow resistances of perifollicular arteries. Follicular fluid concentrations of nitrite/nitrate were inversely correlated with embryo quality (r = -0.613; P = 0.005) and perifollicular artery pulsatility index (r = -0.609; P = 0.021). CONCLUSIONS: L-Arginine supplementation may be detrimental to embryo quality and pregnancy rate during controlled ovarian hyperstimulation cycles.  (+info)

A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. (7/102)

BACKGROUND: The case fatality rate of severe malaria remains unacceptably high. N-acetylcysteine (NAC) is a safe compound that inhibits tumour necrosis factor (TNF) and impedes cytoadherence, both of which have been implicated in the pathogenesis of malaria complications. AIM: To evaluate NAC as adjunctive therapy in severe malaria. DESIGN: A placebo-controlled, double-blind prospective study, with serum lactate level as the principal objective measure of response. METHODS: Thirty adult males with severe, quinine-treated malaria received either 300 mg/kg of NAC or placebo, over 20 h. RESULTS: Serum lactate levels normalized twice as quickly after NAC (median 21 h, 95%CI 12-36 h) as after placebo (median 42 h, 95%CI 30-84 h; p=0.002, Mann-Whitney U test). Twenty-four hours after admission, 10/15 (67%) NAC-group patients but only 3/15 (20%) placebo-group patients had normal lactate concentrations (p=0.01, Fisher exact test). NAC-treated patients could be switched from intravenous to oral therapy earlier than individuals who received placebo (42 h vs. 51 h after admission) but the difference was not significant (p=0.28, Mann-Whitney U test). DISCUSSION: NAC's mechanism of action in malaria is unclear, since it did not markedly alter plasma cytokine profiles. Trials of NAC adjunctive therapy for complicated malaria, with mortality as an endpoint, appear to be warranted.  (+info)

Intestinal absorption enhancement of the ester prodrug tenofovir disoproxil fumarate through modulation of the biochemical barrier by defined ester mixtures. (8/102)

The effect of discrete esters and ester mixtures on the intestinal stability and absorption of tenofovir disoproxil fumarate (tenofovir DF, an esterase-sensitive prodrug of the antiviral tenofovir) was compared with the effect of strawberry extract, which has been shown to enhance the absorption of the prodrug across Caco-2 monolayers and in rat ileum. In addition, the mechanism of absorption enhancement was investigated. In rat intestinal homogenates, complete inhibition of the conversion of tenofovir DF (as obtained by strawberry extract) could only be obtained at relatively high concentrations of the discrete esters or by using mixtures of esters (e.g., propyl p-hydroxybenzoate 0.02%, octyl acetate 0.02%, ethyl caprylate 0.01%). Coincubation of tenofovir DF with this mixture also resulted in an enhancement of its absorption in the in vitro Caco-2 system as well as in rat ileum. As tenofovir DF is a substrate for P-glycoprotein (P-gp)-related efflux carriers in the Caco-2 model, the modulatory effect of the ester mixtures was studied on the functionality of P-gp using cyclosporin A (CsA) as a model substrate. Strawberry extract as well as the mixture of three esters interfered with the absorptive transport of CsA across Caco-2 monolayers, illustrating that both mixtures interfere with both esterase-activity and P-gp functionality. This concerted barrier was not observed in rat ileum, suggesting differential functional activities of the biochemical barrier toward tenofovir DF in different absorption systems. Overall, our results illustrate that modulation of the biochemical barrier (metabolism and efflux) of tenofovir DF by ester mixtures can be used to increase the intestinal absorption of tenofovir DF in an in vitro and an in situ absorption model; the mechanism of action appears to be a complex interplay of different systems; the differential expression of carriers and enzymes in different systems illustrates the difficulty of extrapolating observations between different systems/species.  (+info)

Polyethylene Glycol 4000 for Pharmaceutical Adjuvant picture from ANSHAN HENGTAI PHARMACEUTICAL EXCIPIENTS MANUFACTURING CO., LTD view photo of Polyethylene Glycol, Top Quality Peg-4000, High Purity Peg- 4000.Contact China Suppliers for More Products and Price.
Restrictive Procedures:. Restrictive weight reduction surgical procedure works by altering the scale of the abdomen, to scale back the quantity of meals that may be consumed at one time. It doesnt, nonetheless, intervene with the conventional absorption or digestion of meals. A restrictive weight reduction surgical procedure includes the creation of a small abdomen pouch within the higher portion of the abdomen. The capability of this pouch is about one half to at least one ounce. The pouch then connects to the remainder of the abdomen by an outlet generally known as a stoma. The lowered abdomen capability permits the affected person to really feel fuller with much less meals, and by reducing general meals consumption, the affected person can obtain sustained weight reduction. The success of this weight reduction surgical procedure finally relies upon upon the power of the affected person to change his or her consuming habits. After surgical procedure, its doubtless that the affected person ...
Hydrogen peroxide (skin antiseptic) skin antiseptic for hands and body, inflammatory diseases of the mucous membranes, purulent wounds
TY - JOUR. T1 - Amino acids protect epithelial cells from local toxicity by absorption enhancer, sodium laurate. AU - Yata, Takashi. AU - Endo, Yoko. AU - Sone, Miki. AU - Ogawara, Ken Ichi. AU - Higaki, Kazutaka. AU - Kimura, Toshikiro. PY - 2001. Y1 - 2001. N2 - To develop the safe absorption-enhancing formulation attenuating the local toxicity caused by an absorption enhancer, sodium laurate (C12), the effects of amino acids on the local toxicity by C12 were examined in rats. The absorption of phenol red, an unabsorbable marker drug, was significantly enhanced by 10 mM C12 in an in situ colon loop study and the addition of L-glutamine (L-Gln), L-arginine, or L-methionine at 10 mM did not change the promoting effect of C12. However, C12 significantly increased the elution of phospholipids, total protein, and lactate dehydrogenase, which are markers for local toxicity, from colon, but these amino acids attenuated the local toxicity caused by C12 significantly. Transport study using an ...
Buying cheap Armodafinil and good quality medication online is a tiring job. If you want to buy cheap Armodafinil then is the best website you can buy your medication. provides you with top notch quality of products with easy order option, without troubling you to fill long forms. There are easy paying options and the delivery is made to you within 5 working days. You can get 30 pills free with your order on payment of e-check and cash on delivery. ...
Honest user experience and ratings about armodafinil medications. Read what customers think about these smart pills: benefits, side effects, and interactions. Here you can see the most recent armodafinil reviews.
The treatment of stable non-segmental vitiligo is often challenging, which new therapies are being searched. Multiple clinical trials have proposed
Buy Armodafinil online at cheap prices . Its doctors recommended medication for treating the problem of excessive day time sleepiness. Order now!
Use of smart drugs is on the rise. To be safe and to accrue maximum benefits, it is important for people to understand the difference between various drugs.
Pill with imprint C 205 is White, Round and has been identified as Armodafinil 50 mg. It is supplied by Teva Pharmaceuticals USA, Inc..
The photoreduction of water-soluble cationic manganese (III) meso-tetrakis (1-methylpyridium-4-yl)porphyrin (Mn-III(TMPyP)(4+)) bound to a synthetic polynucleotide, either poly[d(A-T)(2)] or poly[d(G-C)(2)], was examined by conventional absorption and circular dichroism (CD) spectroscopy, transient absorption, and transient Raman spectroscopy. Upon binding, Mn-III(TMPyP)(4+) produced a positive CD signal for both polynucleotides, suggesting external binding. In the poly[d(A-T)(2)]-Mn-III(TMPyP)(4+) adduct case, an interaction between the bound porphyrin was suggested. The transient absorption spectral features of Mn-III(TMPyP)(4+) in the presence of poly[d(A-T)(2)] and poly[d(G-C)(2)] were similar to those of the photoreduced products, Mn-II(TMPyP)(4+), whereas Mn-III(TMPyP)(4+) in the absence of polynucleotides retained its oxidation state. This indicated that both poly[d(A-T)(2)] and poly[d(G-C)(2)] act as electron donors, resulting in photo-oxidized G and A bases. The transient Raman bands ...
Fatigue is a common problem for many people with HIV/AIDS, interfering with daily activities and serving as a significant barrier to working among those whose health is otherwise stable or restored by antiretroviral (ARV) medication. Fatigue in HIV is associated with disability and diminished quality of life. It may be caused by ARVs or by the virus itself. A related study tested whether modafinil, of which armodafinil is an r-isomer, could reduce fatigue in HIV/AIDS patients. Armodafinil, believed to have a longer duration and greater effect than modafinil, will be tested on the same criteria.. Participants will be randomly assigned to receive either armodafinil or a placebo daily for 4 weeks. Participants randomized to active medication and who show improvements in symptoms will be offered armodafinil for an additional 12 weeks. For them, the study duration is 16 weeks. Participants who did not receive armodafinil will be offered armodafinil for 16 weeks. For these participants, the study ...
Fatigue is a common problem for many people with HIV/AIDS, interfering with daily activities and serving as a significant barrier to working among those whose health is otherwise stable or restored by antiretroviral (ARV) medication. Fatigue in HIV is associated with disability and diminished quality of life. It may be caused by ARVs or by the virus itself. A related study tested whether modafinil, of which armodafinil is an r-isomer, could reduce fatigue in HIV/AIDS patients. Armodafinil, believed to have a longer duration and greater effect than modafinil, will be tested on the same criteria.. Participants will be randomly assigned to receive either armodafinil or a placebo daily for 4 weeks. Participants randomized to active medication and who show improvements in symptoms will be offered armodafinil for an additional 12 weeks. For them, the study duration is 16 weeks. Participants who did not receive armodafinil will be offered armodafinil for 16 weeks. For these participants, the study ...
TY - JOUR. T1 - Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer. AU - Gopalakrishnan, Shobha. AU - Pandey, Niranjan. AU - Tamiz, Amir P.. AU - Vere, John. AU - Carrasco, Rosa. AU - Somerville, Robert. AU - Tripathi, Amit. AU - Ginski, Mark. AU - Paterson, Blake M.. AU - Alkan, Sefik S.. PY - 2009/1/5. Y1 - 2009/1/5. N2 - Tight junctions (TJs) are intercellular structures that control paracellular permeability and epithelial polarity. It is now accepted that TJs are highly dynamic structures that are regulated in response to exogenous and endogenous stimuli. Here, we provide details on the mechanism of action of AT-1002, the active domain of Vibrio choleraes second toxin, zonula occludens toxin (ZOT). AT-1002, a hexamer peptide, caused the redistribution of ZO-1 away from cell junctions as seen by fluorescence microscopy. AT-1002 also activated src and mitogen activated protein (MAP) kinase pathways, increased ZO-1 tyrosine phosphorylation, ...
Vaccines can have adverse side-effects, and these are predominantly associated with the inclusion of chemical additives such as aluminum hydroxide adjuvant. The objective of this study was to establish an in vitro model system amenable to mechanistic investigations of cytotoxicity induced by hepatitis B vaccine, and to investigate the mechanisms of vaccine-induced cell death.. ...
TY - JOUR. T1 - Adjunct Therapy in STEMI Intervention. AU - Mehta, Sameer. AU - Alfonso, Carlos E.. AU - Oliveros, Estefania. AU - Shamshad, Faisal. AU - Flores, Ana I.. AU - Cohen, Salomon. AU - Falcão, Esther. N1 - Copyright: Copyright 2010 Elsevier B.V., All rights reserved.. PY - 2010/2. Y1 - 2010/2. N2 - ST-elevation myocardial infarction (STEMI) interventions have significantly reduced mortality and morbidity from acute myocardial infarction. Compulsive management of thrombus is a fundamental requirement of these interventions. A pragmatic thrombus-guided management strategy is reviewed along with additional novel therapeutic adjuncts for STEMI interventions.. AB - ST-elevation myocardial infarction (STEMI) interventions have significantly reduced mortality and morbidity from acute myocardial infarction. Compulsive management of thrombus is a fundamental requirement of these interventions. A pragmatic thrombus-guided management strategy is reviewed along with additional novel therapeutic ...
A method of inducing hyperthermia in at least a portion of a target area-e.g., a tumor or a portion of a tumor or targeted cancerous cells-is provided. Targeted RF absorption enhancers, e.g., antibodies bound to RF absorbing particles, are introduced into a patient. These targeted RF absorption enhancers will target certain cells in the target areas and enhance the effect of a hyperthermia generating RF signal directed toward the target area. The targeted RF absorption enhancers may, in a manner of speaking, add one or more RF absorption frequencies to cells in the target area, which will permit a hyperthermia generating RF signal at that frequency or frequencies to heat the targeted cells.
Buy Armodafinil Online USA - Visit Med All Day to buy Armodafinil tablets Online with express shipping all over USA. Best offers available shop now.
Roundup is safe for dogs and has virtually no health risks when used properly, according to the Roundup website. Once the application of Roundup is finished and the weedkiller has dried, dogs can use...
Generic Artvigil 150 mg Armodafinil at ModafinilXL Shop Online. Artvigil 150 mg Armodafinil 10 Samples Is Already in Your Cart. Fast Delivery and Professional Tracking System.
Cheap probenecid guidelines, Probenecid online payment mail order, Order probenecid roche, Discount probenecid royal, Probenecid shop japan, Generic probenecid buy visa otc, Buy probenecid rezeptfrei
YourStory presents this daily roundup of the latest startup news and updates from the Indian startup ecosystem and beyond. Heres the roundup for Wednesday, July 28, 2021.
This edition of Ranch Roundup features information about turf improvements, security contracts and events like Food Truck Night.. View Aug./Sept. Ranch Roundup. View Sept. Activity Calendar. ...
File RoundUp combines the fastest cataloger and the most powerful search function available and batch file capabilities to provide the ultimate file utility File RoundUp is over twice as fast as CDFinder and DiskTrackeron Jaquar and even faster
vomiting, that affect the result are often unknown. In contrast to the therapeutic setting, atypical solubility characteristics are noted, and saturation of enzymatic processes occurs. Intestinal or hepatic enzymatic saturation or alterations in transporters may lead to enhanced absorption through a decrease in first-pass effect. Metabolism before the xenobiotic reaches the blood is referred to as the first-pass effect.2,76 Saturation of plasma protein binding results in more free xenobiotic available in the serum, plasma, and blood. Saturation of hepatic enzymes or active renal tubular secretion leads to prolonged elimination. In addition, age, obesity, gender, genetics, chronopharmacokinetics (diurnal variations), and the effects of illness and compromised organ perfusion all further inhibit attempts to achieve precise analyses.3,17,40,45,68,72 In addition, various treatments may alter one or more pharmacokinetic and toxicokinetic ...
Care and prudent medical judgment should be exercised when switching, particularly from long-acting agents. One day, robaxin over the counter uk I was in a grocery store shopping, pushing a grocery cart, and a little boy walked in front of me pushing a toy cart? Tadagra le spécialiste est fait par le produit Intas pharmaceutique. Prescription drugs can be both helpful and harmful? They are one of the most common ways for rewards to be distributed, robaxin over the counter uk and there are a large variety of cubes available, which can be obtained by various means? Also, aspirin may compete with penicillin for renal tubular secretion, increasing penicillin serum concentrations! However, it must do much more than determine whether the penalty was lawfully imposed? She has no other medical problems and takes no medication. I was curious to know how you center yourself and clear your head prior to writing? A battery of 11 cognitive tests, including those recommended by the Statement of Consensus ...
Curious about differences between Armodafinil vs. Modafinil? Then youre in the perfect place. In the #1 GUIDE, we compare side effects, half-life, and more.
Roundup PRO® Concentrate is part of the Industrial, Turf and Ornamental family and helps control weeds and brush through a more concentrated formulation.
This weeks Research Roundup highlights the clinical and pathology findings associated consistently with larger glomerular volume.
In this weeks round-up we decided to stop procrastinating thanks to some great advice and concentrate on achieving our goals, managing remote teams and sched
A roundup of industry expertise, exclusive resources, business support and tools to help your design business survive and thrive.
This past week was really rough - quite bluntly, we were due for a bad news cycle, and we absolutely got one. (In fact, a particularly keen observer might notice that these write-ups only ever issue on Mondays during rough news cycles, because I need the extra day to wrack my brain for that spoonful of sugar…
A recent study has found that the levels of Roundup and other dangerous chemicals making into most of our food supplies are shocking and scary.
A bumper round-up of PR news from the last two weeks, featuring Cisions latest white paper, senior hires at Newgate and Hills Balfour, and wins for Fever ...
The 9to5Linux Weekly Roundup for August 8th, 2021, brings news about UnityX 10, Nitrux 1.5.1, Ubuntus new Desktop Installer, and much more.
Welcome to the Mile High Roundup, a look at some of the interesting things that have happened over the past two weeks in the tech scene in Boulder,
With the NBA draft just nine days away, heres a roundup of mock drafts, along with projections for the Sixers at No. 15. - Sheil Kapadia, Philadelphia
A roundup of managed services (MSP) news includes expansion by Autotask, integration from Level Platforms and more. Page: 3
Join Dennis Taylor for an in-depth discussion in this video Working with ROUND, ROUNDUP, and ROUNDDOWN, part of Excel 2011 for the Mac: Advanced Formulas and Functions
We have our wonderfully fun adventure days coming up this summer.  For June we have two Cowboy Roundup themed days.  The first went great, dont miss your chance to get in on the second on coming up on the 25th of June!
This months disciplinary roundup features an excessive and disproportionate fine halved and a student who in a desperate attempt to save his career forge
Netbook Choices roundup of netbook reviews from around the web on Monday 30th March 2009. Asus Eee PC 1000HE video review @ JKK Mobile Rating: N/A
In terms of medical adjunctive therapies, we offer a large variety from Traditional European Medicine (TEM) as well as from Traditional Chinese Medicine (TCM) …
It is also used for liver cirrhosis, kidney impairment, nephrotic syndrome, in adjunct therapy for swelling of the brain or lungs where rapid diuresis is
probenecid auf nachnahme bestellen, wo bekomme ich günstig probenecid her, probenecid kaufen online In unserer Versandapotheke kГ¶nnen Sie Medikamente bis...
Waklert 150 uk armodafinil waklert review waklert online uk waklert review modalert or waklert waklert australia legal waklert australia legal waklert armodafinil
The day of a persons life goes well when all the things of the day goes well. There can be many of the activities which can go around to be performed and completed. ...
The Negotiator is the leading and longest established media brand serving the UK residential property market. The Negotiator is online and in print, with 20,000 glossy magazines distributed to UK agencies every month and hosts annually The Negotiator Awards and The Negotiator Conference & Expo.
Exposure to glyphosate-the worlds most widely used, broad-spectrum herbicide and the primary ingredient in the weedkiller Roundup-increases the risk of s - Natural Health Resource - The worlds most widely referenced, open access, natural medicine database, with 30,000+ study abstracts and growing daily
Please note: All linked articles are published independently to this guide, and we are not responsible for any material you may find via those references ...
After the disappointment of being disqualified for alleged drafting in the British Time Trial Championship last weekend, I-Ride Racing
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok ...
T. Rudzki, C. Earnshaw, D. Murphy and G. Kearney, SALTE Pt. 2: On the Design of the SALTE Audio Rendering Engine for Spatial Audio Listening Tests in VR in Audio Engineering Society 147 ...
One of the most challenging parts of having three children of different ages is that they seem to pick up sicknesses then pass them to each other, and just
We round up the recruitment news this week, including new relationship managers at Clariden Leu, a new VP of business development at Pictet Asset Management and an addition to Sanford C Bernsteins Asia team.
New regulations for bobby calves: New regulations to strengthen the law around the management and treatment of bobby calves are planned to be in place before the 2016 spring calving season, Primary Industries Minister Nathan Guy has announced today.
Welcome to the final post in my series focused on providing a set of revision notes for the MB-400: Microsoft Power Apps + Dynamics 365 Developer exam. In today’s post, I wanted to consolidate all of the content from the series into a single, concise post for ease of access. I’ll also provide some general advice and tips that I hope will come in useful for when you sit the exam.
Fleetwood Town were in the community celebrating the fifth annual EFL Day of Action, with activities with the local community planned throughout the day, linking everyone from the first-team, to the Under-18s, and the supporters - heres what they got up to!
Beta-glucan Immunomodulator Immunostimulant Pharmaceutic adjuvant "Guideline on Adjuvants in Vaccines for Human Use" (PDF). The ... Look up adjuvant in Wiktionary, the free dictionary. Scholia has a profile for immunologic adjuvant (Q967453). Adjuvant therapy ... Freund's complete adjuvant, Freund's incomplete adjuvant Other organic substances: squalene There are many adjuvants, some of ... The word "adjuvant" comes from the Latin word adiuvare, meaning to help or aid. "An immunologic adjuvant is defined as any ...
... adjuvants, pharmaceutic MeSH D27.720.744.523 - ointment bases MeSH D27.720.744.771 - preservatives, pharmaceutical MeSH D27.720 ... adjuvants, anesthesia MeSH D27.505.954.427.020 - alcohol deterrents MeSH D27.505.954.427.040 - analgesics MeSH D27.505.954.427. ... adjuvants, immunologic MeSH D27.505.696.477.274.400 - interferon inducers MeSH D27.505.696.477.656 - immunosuppressive agents ...
... adjuvants, pharmaceutic MeSH D26.650.523 - ointment bases MeSH D26.650.771 - preservatives, pharmaceutical MeSH D26.650.931 - ...
Enzyme catalysis Industrial catalysts Kelvin probe force microscope Limiting reagent Murburn concept Pharmaceutic adjuvant ...
Paul U. Unschuld points out that this is similar etymology to the Greek pharmakon and so he uses the term "pharmaceutic". Thus ... as an adjuvant for cancer immunotherapy, appears to have the potential for toxicity. Also, adulteration of some herbal medicine ...
Pharmaceutic Adjuvant Calcium stearate Powder. Min.Order: 25 Kilogram. FOB Price: USD $ 7.0-7.0/Kilogram ...
The differences between 13V-LE and Infuvite Adult are their form and pharmaceutic adjuvants. Tween 80 is used to solubilize the ...
Pharmaceutic adjuvant L(+)-Tartaric acid CAS 87-69-4. Posted on March 20, 2021. June 10, 2021. Categories Acid, Tartaric acid ... Leave a comment on Pharmaceutic adjuvant L(+)-Tartaric acid CAS 87-69-4 SODIUM TARTRATE 868-18-8. ...
Adjuvants, Pharmaceutic. General subdivision. congresses.. 700 1# - ADDED ENTRY--PERSONAL NAME. Personal name. Salmon, Sydney E ... Proceedings of the Third International Conference on the Adjuvant Therapy of Cancer, Tucson, Arizona, March 18-21, 1981.--Page ...
Adjuvant, Pharmaceutic Adjuvant, Pharmaceutical Adjuvants, Pharmaceutical Pharmaceutic Adjuvant Pharmaceutic Adjuvants ... Adjuvant, Pharmaceutic. Adjuvant, Pharmaceutical. Adjuvants, Pharmaceutical. Pharmaceutic Adjuvant. Pharmaceutic Adjuvants. ... Adjuvants, Pharmaceutic - Preferred Concept UI. M0000432. Scope note. Agents that aid or increase the action of the principle ... Adjuvants, Pharmaceutic Entry term(s). ... Pharmaceutic Aids (1968-1974). Public MeSH Note:. 75; was see ...
Adjuvants, Immunologic--congresses.. Adjuvants, Pharmaceutic--congresses. National Library of Medicine Call No.: QZ 267 ... Adjuvant therapy of cancer III / Adjuvant therapy of cancer III / edited by Sydney E. Salmon, Stephen E. Jones. - New York : ... "Proceedings of the Third International Conference on the Adjuvant Therapy of Cancer, Tucson, Arizona, March 18-21, 1981."--Page ...
AAG buffer solution-Tianjin berens biotechnology co., LTD
", "Drug Tolerance"[Mesh], "Adjuvants, Pharmaceutic"[Mesh], "adjuvant analgesics", "pregabalin "[Substance Name], "Ketamine"[ ... but they may serve as adjuvant therapy. Education about analgesic use was frequently, but not invariably, found to reduce pain ...
Info Adjuvants, Pharmaceutic. * Info Antirheumatic Agents. * Info Gout Suppressants. * Info Pharmaceutic Aids ...
Adjuvants, Pharmaceutic. *Adolescent. *Adrenal Cortex Hormones. *Adult. *Aged. *Aged, 80 and over ...
Adjuvants, Pharmaceutic - therapeutic use Adult Blood - metabolism Carrier Proteins - metabolism Cleavage Stage, Ovum Female ... Further, to investigate whether GH is a more effective adjuvant if the standard treatment regimen is preceded by GH injections ... the overall results did not support GH as a clinically useful adjuvant treatment. ... Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. https://arctichealth. ...
... evidence boosters can usually get precious yourself or maybe while evidence adjuvants using pharmaceutic pill drug treatments. ...
Acrylamides, Adenoviridae, Adjuvants, Pharmaceutic, Analysis of Variance, Animals, Breast Neoplasms, Combined Modality Therapy ...
Adjuvants, Immunologic Adjuvants, Pharmaceutic Articles Humans Influenza, Human Influenza Vaccines *. Source: Public Health Rep ... Title : Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule Personal Author(s) : ... Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule. ... Relative merits of aqueous and adjuvant influenza vaccines when used in a two-dose schedule ...
Abbreviation: AHT, adjuvant hormone therapy.. a Women who were not dually eligible for Medicare, who were aged 21 to 64 years ... Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol 2001;19(2):322-8. PubMed ... Improving Adjuvant Hormone Therapy Use in Medicaid Managed Care-Insured Women, New York State, 2012-2014. Prev Chronic Dis 2016 ... Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer. J Natl Cancer Inst 2012;104( ...
Pharmaceutic adjuvant. *Phase Boundary Catalysis. *Phase transfer catalyst. *Photocatalysis. *Ribozyme (RNA Biocatalysis) ...
Adjuvants, Immunologic 1 * Adjuvants, Pharmaceutic 1 * Administrative Personnel 1 * Adolescent 1 * Adolescent Development - ...
Sterile APIs、Pharmaceutic Adjuvant L-Arginine and its derivatives Other Amino acids D-Amino Acids Calcium ketoates Pantoic ...
239000002671 adjuvant Substances 0.000 description 5 * 230000000240 adjuvant Effects 0.000 description 5 ... 239000000546 pharmaceutic aid Substances 0.000 description 7 * 239000000047 product Substances 0.000 description 7 ...
Nissui Pharmaceutic Co. Ltd, Tokyo, Asia) formulated with 10% fetal leg serum (Bio Western world, Beginning, Portugal) and ... become 1374601-40-7 IC50 regarded as as a potential book adjuvant therapy. Methods and Design Patients, reagent and antibodies ...
Based on the pathological diagnosis of high-grade (G3) urothelial carcinoma (ypT3aN2), two more cycles of adjuvant chemotherapy ... The "dextran-magnetic layered double hydroxide-fluorouracil" (DMF) drug delivery system is a new type of pharmaceutic ... Total Mesometrial Resection With (Neo)Adjuvant Chemotherapy in Locally Advanced Cervical Cancer: A Tumor Response Score. ... CASE PRESENTATION: A 69-year-old man received adjuvant chemoradiotherapy post-operatively. He underwent thoracic re-irradiation ...
Innovative Drug Process Study & Filing Pharmaceutic Preparation Preformulation Study Formulation Technology Research ... In addition, immunotherapy can be used as an important anti-tumor adjuvant therapy besides chemotherapy, radiotherapy, and ...
Pharmaceutic Adjuvants. Rabeprazole sodium intermediates. Lansoprazole intermediates. Pantoprazole Intermediates. Omeprazole/ ...
Pharmaceutic" by people in this website by year, and whether "Adjuvants, Pharmaceutic" was a major or minor topic of these ... "Adjuvants, Pharmaceutic" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH (Medical ... Below are the most recent publications written about "Adjuvants, Pharmaceutic" by people in Profiles. ... Below are MeSH descriptors whose meaning is more general than "Adjuvants, Pharmaceutic". ...
Sterile APIs、Pharmaceutic Adjuvant L-Arginine and its derivatives Other Amino acids D-Amino Acids Calcium ketoates Pantoic ...
GUIZHOU XINZIHONG PHARMACEUTIC ADJUVANT CO.LTD. 540725476. manufacture(79606-002) Establishment. Name. Address. ID/FEI. ...
Adjuvants, Pharmaceutic / therapeutic use* Actions. * Search in PubMed * Search in MeSH * Add to Search ... Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147) Ahmet Ozer Sehirli 1 ... Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147) Ahmet Ozer Sehirli ... Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of ...
Adjuvants, Pharmaceutic* Actions. * Search in PubMed * Search in MeSH * Add to Search ...
Adjuvant, Pharmaceutic Adjuvant, Pharmaceutical Adjuvants, Pharmaceutical Pharmaceutic Adjuvant Pharmaceutic Adjuvants ... Pharmaceutic Aids [D27.720.744] * Adjuvants, Pharmaceutic [D27.720.744.064] * Adjuvants, Vaccine [D27.720.744.064.500] ... Pharmaceutic Aids (1968-1974). See Also. Adjuvants, Immunologic. Public MeSH Note. 75; was see under PHARMACEUTIC AIDS 1969-74 ... Adjuvants, Pharmaceutic Preferred Term Term UI T000879. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1975). ...
Ethyl Cellulose (Pharmaceutic Adjuvant). 9004-57-3 View Detail * Methyl cellulose. 9004-67-5 View Detail ...
Adjuvant, Pharmaceutic Adjuvant, Pharmaceutical Adjuvants, Pharmaceutical Pharmaceutic Adjuvant Pharmaceutic Adjuvants ... Adjuvant, Pharmaceutic. Adjuvant, Pharmaceutical. Adjuvants, Pharmaceutical. Pharmaceutic Adjuvant. Pharmaceutic Adjuvants. ... Adjuvants, Pharmaceutic - Preferred Concept UI. M0000432. Scope note. Agents that aid or increase the action of the principle ... Adjuvants, Pharmaceutic Entry term(s). ... Pharmaceutic Aids (1968-1974). Public MeSH Note:. 75; was see ...
Adjuvant, Pharmaceutic Adjuvant, Pharmaceutical Adjuvants, Pharmaceutical Pharmaceutic Adjuvant Pharmaceutic Adjuvants ... Pharmaceutic Aids [D27.720.744] * Adjuvants, Pharmaceutic [D27.720.744.064] * Adjuvants, Vaccine [D27.720.744.064.500] ... Pharmaceutic Aids (1968-1974). See Also. Adjuvants, Immunologic. Public MeSH Note. 75; was see under PHARMACEUTIC AIDS 1969-74 ... Adjuvants, Pharmaceutic Preferred Term Term UI T000879. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1975). ...
Pharmaceutic Adjuvants 16% * Drug Liberation 16% * Hardness 9% * Metformin 8% * Weights and Measures 5% ...
Pharmaceutic adjuvant L(+)-Tartaric a.... - show - * SODIUM TARTRATE 868-18-8. - show - ...
Pharmaceutic adjuvant. *Immunostimulant. *Immunomodulator. External links[edit]. *Recommendations for Use and ... Medzhitov R, ... Immunologic adjuvant. ... essential adapter proteins in TLR signaling), they were still able to induce inflammatory responses, ...
Adjuvants, Pharmaceutic. Hypnotics and Sedatives -- therapeutic use 3. The modern and humane treatment of the morphine disease ...
239000000546 pharmaceutic aid Substances 0.000 claims description 10 * 239000004472 Lysine Substances 0.000 claims description ... 239000002671 adjuvant Substances 0.000 claims description 19 * 230000000240 adjuvant Effects 0.000 claims description 19 ...
Hydroxypropyl Methyl Cellulose Category: Pharmaceutic adjuvant Character:White or off-white fibrous or grain powders, no smell ... Hydroxypropyl Methyl Cellulose Category: Pharmaceutic adjuvant Character:White or off-white fibrous or grain powders, no smell ...
Pharmaceutic Adjuvants. Rabeprazole sodium intermediates. Lansoprazole intermediates. Pantoprazole Intermediates. Omeprazole/ ...
Immunological T000875Immunological Adjuvant T000876Pharmaceutic Adjuvants T000877Adjuvant, Pharmaceutic T000878Pharmaceutic ... Freund T017012Freund Adjuvant T017013Adjuvant, Freunds T017013Freunds Adjuvant T017013Freunds Adjuvant T017014Ataxia, ... Graduate Pharmaceutic T013821Graduate Pharmaceutic Education T013822Education, Pharmaceutic, Graduate T013823Pharmaceutic ... Pharmaceutic, Continuing T013815Continuing Pharmaceutic Education T013815Education, Continuing Pharmaceutic T013815Pharmaceutic ...
... or since evidence adjuvants using pharmaceutic prescription drug drug treatments. Lower Sections: Gingery could possibly bump ...
It is subject to suitable pharmaceutic adjuvant and turbid liquor medicament is …China Stone Impact Crusher manufacturers - ...
Adjuvants, Immunologic Adjuvants, Pharmaceutic. 1 Breast Neoplasms diagnosis. 1 drug therapy Showing 1 - 1 results of 1 for ... International Conference on Adjuvant Therapy of Primary Breast Cancer 1 Senn, Hansjörg 1 ...
Adjuvants, Pharmaceutic 1 * Adolescent 4 * Adolescent Medicine 4 * Adrenocortical hyperfunction 1 * Aftercare 1 ...
Sterile APIs、Pharmaceutic Adjuvant L-Arginine and its derivatives Other Amino acids D-Amino Acids Calcium ketoates Pantoic ...
Quinoa saponin compositions and use as immunological adjuvants. US 5597807 (1994) * Cytoplasmic male sterile quinoa. WO 1993/ ... Use of quinoa extract as cosmetic and pharmaceutic slimming agent. US 2010/061945 (2006) * Infant formula composition ...
L. F. Hernandez-Aya and A. M. Gonzalez-Angulo, "Adjuvant systemic therapies in breast cancer," Surgical Clinics for North ... caramanicus extract has a potential antiproliferative/proapoptotic property in MCF-7 cells and can be used as pharmaceutic case ...
Adjuvants, Anesthesia Adjuvants, Immunologic Adjuvants, Pharmaceutic Administration, Buccal Administration, Cutaneous ... Adjuvant Chemotherapy, Cancer, Regional Perfusion Chemotherapy-Induced Febrile Neutropenia Chenodeoxycholic Acid Chenopodiaceae ... Adjuvant Chemoreceptor Cells Chemosterilants Chemotactic Factors Chemotactic Factors, Eosinophil Chemotaxis Chemotaxis, ... Pharmaceutic Dictionaries, Polyglot Dictionary Dictyocaulus Dictyocaulus Infections Dictyosteliida Dictyostelium Dicumarol ...
  • Based on the pathological diagnosis of high-grade (G3) urothelial carcinoma (ypT3aN2), two more cycles of adjuvant chemotherapy with gemcitabine and cisplatin were administered. (
  • Four months after completing adjuvant chemotherapy, pulmonary and hepatic metastases appeared, and treatment with pembrolizumab was initiated. (
  • In addition, immunotherapy can be used as an important anti-tumor adjuvant therapy besides chemotherapy, radiotherapy, and surgery. (
  • Proceedings of the Third International Conference on the Adjuvant Therapy of Cancer, Tucson, Arizona, March 18-21, 1981. (
  • International Conference on the Adjuvant Therapy of Cancer. (
  • Adjuvant therapy of cancer III / edited by Sydney E. Salmon, Stephen E. Jones. (
  • In 2010, national guidelines recommended that women with nonmetastatic, hormone receptor-positive breast cancer take adjuvant hormone therapy for 5 years. (
  • This article describes a coordinated quality improvement pilot conducted by a state department of health and Medicaid managed care plans to engage women in guideline-concordant adjuvant hormone therapy. (
  • Adjuvant hormone therapy status was determined from Medicaid pharmacy data. (
  • Adjuvant hormone therapy status in the 6 months following outreach was evaluated. (
  • This pilot suggests outreach conducted by health plan care managers, facilitated by linked Medicaid and Cancer Registry data, is an effective method to improve adjuvant hormone therapy initiation and adherence rates in Medicaid managed care-insured women. (
  • Adjuvant hormone therapy (AHT) works either by lowering hormone levels or blocking the action of hormone on tumor cells, and it reduces annual recurrence rates by approximately 40% as well as improves survival rates (9-11). (
  • Further, to investigate whether GH is a more effective adjuvant if the standard treatment regimen is preceded by GH injections. (
  • Adjuvants, Pharmaceutic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (